MedMira Files Patent Application for Next Generation Rapid Test
19-Mar-2008
"Our new test platform provides the user with an even simpler, user-friendly testing procedure than we currently offer in our rapid tests, without sacrificing the high quality and consistent performance that MedMira has built its reputation on," said Dr. Neeraj Vats, Vice President of Technology & Intellectual Property, MedMira Inc. "The new test platform makes it possible to perform a rapid, flow-through test in just two easy steps."
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.